RCE 0.97% 52.0¢ recce pharmaceuticals ltd

Ann: HREC Approval to Start Phase I/II Burns Wound Study, page-33

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,301 Posts.
    lightbulb Created with Sketch. 1132
    Well I am surprised this has gone down on such good news. 'Theoretically' the sign of a weak stock - oh well just have to look for a top into my LT holdings.

    My reading of it is phase 1/2 human tropical with phase 1 human IV in parallel / side by side. They are not so specific on IV timelines etc in IV ann said screening Q4 2020 so could be happening now & 48 IV test candidates ready to run 'in parallel' with 30 tropical candidates. 'in parallel' is open to interpretation at present.

    A$30 Mil in the bank to progress this, have the green light for phase 1 & 2 human tropic & phase 1 human IV 'in parallel' - I'm liking it.

    https://hotcopper.com.au/data/attachments/2565/2565573-9177234b09bc399852640ddb303ce8d9.jpg

    IV

    https://themarketherald.com.au/recce-pharmaceuticals-asxrce-enlists-cmax-clinical-research-for-phase-1-study-2020-09-11/

    https://hotcopper.com.au/data/attachments/2565/2565590-38ea8c8003569a46179e16c7190e04df.jpg
    .


    .
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.